0001209191-20-011718.txt : 20200221 0001209191-20-011718.hdr.sgml : 20200221 20200221182718 ACCESSION NUMBER: 0001209191-20-011718 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200219 FILED AS OF DATE: 20200221 DATE AS OF CHANGE: 20200221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Fred M CENTRAL INDEX KEY: 0001331339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 20641519 MAIL ADDRESS: STREET 1: C/O BEJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-19 0 0001016169 ANTARES PHARMA, INC. ATRS 0001331339 Powell Fred M C/O ANTARES PHARMA, INC. 100 PRINCETON STREET SOUTH, SUITE 300 EWING NJ 08628 0 1 0 0 Executive Vice President & CFO Common Stock 2020-02-19 4 A 0 63234 0.00 A 548844 D Common Stock 2020-02-19 4 F 0 23791 3.53 D 525053 D On August 25, 2017, Mr. Powell was granted a performance stock unit award that was contingent upon achieving certain performance goals over the three year performance period ended December 31, 2019. The number of shares acquired represent the total number of shares earned upon achievement of certain performance goals, the achievement of which was certified on February 19, 2020. The shares disposed represents the number of shares withheld to settle tax liability in connection with the vesting of the performance stock unit award. /s/ Keith Muckenhirn as attorney-in-fact for Fred M. Powell 2020-02-21